Compounds > cytarabine

cytarabine and Atherosclerotic Parkinsonism

cytarabine has been researched along with Atherosclerotic Parkinsonism in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bojko, A; Chutorian, AM; Edelberg, D; Frucht, S; Heier, L; Nygaard, T1
Kulkantrakorn, K; Petruska, PJ; Selhorst, JB1
Luque, FA; Petruska, P; Selhorst, JB1

Other Studies

3 other study(ies) available for cytarabine and Atherosclerotic Parkinsonism

ArticleYear
Toxic pediatric parkinsonism: report of a child with metabolic studies and response to treatment.
    Journal of child neurology, 2003, Volume: 18, Issue:11

    Topics: Antimetabolites, Antineoplastic; Antiparkinson Agents; Carbidopa; Child; Cytarabine; Humans; Levodopa; Male; Parkinson Disease, Secondary

2003
Cytosine arabinoside and amphotericin B-induced parkinsonism.
    Annals of neurology, 1996, Volume: 39, Issue:3

    Topics: Amphotericin B; Carbidopa; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelomonocytic, Acute; Levodopa; Lung Diseases; Middle Aged; Parkinson Disease, Secondary

1996
Parkinsonism induced by high-dose cytosine arabinoside.
    Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:3

    Topics: Carbidopa; Cytarabine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Leukemia, Myelomonocytic, Acute; Levodopa; Middle Aged; Parkinson Disease, Secondary

1987